Insights Center

This New York Law Journal special section column discusses some of the lurking pitfalls when the relationship between the government and the private law firms on which the government relies becomes a little too close. The column is authored by Mintz Members David Siegal and Jason P.W. Halperin, both of whom are former federal prosecutors from the U.S. Attorney’s Office for the Southern District of New York. Associate Peter Mulcahy assisted in the preparation of the column.

Apple now says its smartwatch tech to detect atrial fibrillation is not for those with atrial fibrillation

December 6, 2018 | Washington Post

This in-depth Washington Post piece looks at Apple’s latest venture into health care - a new Apple Watch technology to detect atrial fibrillation. The piece notes, however, that the technology is not intended for people who have atrial fibrillation. The Post delves into questions raised by the introduction of a mass-market monitoring tool for the heart. Bethany Hills, Member and Chair of Mintz's FDA practice, is among the industry sources quoted providing commentary in the piece.

Device Expert: FDA De Novo Rule Provides Clarity For Industry

December 5, 2018 | Inside Health Policy

Aaron Josephson, ML Strategies Senior Director who previously worked for the Food & Drug Administration (FDA), discusses the FDA's proposed rule on the de novo pathway. Aaron notes that this could provide necessary clarity for device manufacturers, modernize the 510(k) premarket notification process and help the FDA achieve the performance goals laid out by Congress.

View all News and Press Releases

Events

Jan

2019

14th Annual Directors Forum

San Diego, CA

Jan

2019

Webcast: ITC Section 337 Investigations: Trends and Significant Court Rulings in 2018

Jan

2019

ABA Derivatives and Futures Law Winter Committee Meeting

LaPlaya Beach & Golf Resort - 9891 Gulf Shore Dr, Naples, FL 34108

View all Events